CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 150 enrolled
Drug / intervention
Congo Red test GV-005device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02610972
NCT02610972N/ACompleted
CompareCT.gov

Assessing the Usability and Clinical Utility of the Congo Red Dot Test: A Case-control Study

Gynuity Health Projects·observational·Posted Nov 20, 2015·Updated Sep 20, 2019

In Brief

An observational study evaluating Congo Red test GV-005 for Preeclampsia. Completed, enrolled 150 participants across 2 sites in 2 countries.

Detailed Summary

A case-control study will evaluate the clinical utility of the Congo Red test GV-005 in following women with a clinical diagnosis of preeclampsia and clinically healthy women in the postpartum period

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPreeclampsia
CountriesBangladesh, Mexico
CollaboratorsInternational Centre for Diarrhoeal Disease Research, Bangladesh

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedNov 20, 2015
Enrollment StartDec 1, 2018
Primary CompletionMar 30, 2019
Study CompletionMay 30, 2019
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 10.6 years ago

Interventions

Congo Red test GV-005device

Congo Red test GV-005 test is a simple test has been developed to detect unfolded or misfolded proteins in urine.